Identification of mitophagy-related biomarkers and immune infiltration in major depressive disorder

Jing Zhang1, Shujun Xie2, Rong Xiao3

  • 1The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.

BMC Genomics
|April 25, 2023
PubMed
Abstract

Insights

This study identified five mitophagy-related genes as potential biomarkers for major depressive disorder (MDD), offering new diagnostic tools and insights into MDD

Area of Science:

  • Molecular Biology
  • Genetics
  • Neuroscience

Background:

  • Major depressive disorder (MDD) is a severe mental health condition.
  • Mitophagy, crucial for mitochondrial quality control, is implicated in depression.
  • Research on mitophagy-related genes (MRGs) in MDD is limited.

Purpose of the Study:

  • To identify novel mitophagy-related gene biomarkers for MDD.
  • To explore the molecular mechanisms underlying MDD related to mitophagy.
  • To classify MDD into molecular subtypes based on mitophagy genes.

Main Methods:

  • Analyzed gene expression data from MDD patients and controls.
  • Utilized consensus clustering and immune cell infiltration analysis (CIBERSORT).
  • Applied weighted gene co-expression network analysis and PPI networks to identify key genes; constructed a diagnostic model using LASSO and Cox regression.

Main Results:

  • Identified 315 mitophagy-related differentially expressed genes (MR-DEGs) in MDD.
  • Discovered two distinct MDD clusters with varying immune infiltration.
  • Validated a five-gene signature (MATR3, ACTL6A, FUS, BIRC2, RIPK1) for MDD diagnosis with excellent performance.

Conclusions:

  • A novel five-MRG gene signature demonstrates high diagnostic accuracy for MDD.
  • Established a link between mitophagy-related genes and the immune microenvironment in MDD.
  • Identified two MDD subtypes with distinct mitophagy gene expression profiles.

Related Concept Videos